News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rolph Timothy
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/15/2023 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 509 shares
@ $55.16, valued at
$28.1k
|
|
| 03/14/2023 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 603 shares
@ $43.47, valued at
$26.2k
|
|
| 12/30/2022 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 1,700 shares
@ $50.0038, valued at
$85k
Sold 8,023 shares
@ $50.5481, valued at
$405.5k
Sold 12,293 shares
@ $51.3765, valued at
$631.6k
Exercised 1,700 options to buy
@ $28.35, valued at
$48.2k
Exercised 7,816 options to buy
@ $28.35, valued at
$221.6k
|
|
| 12/20/2022 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 29,073 options to buy
@ $21.1, valued at
$613.4k
|
|
| 12/13/2022 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 19,195 shares
@ $0
Granted 86,379 options to buy
@ $42.95, valued at
$3.7M
|
|
| 11/16/2022 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 3,138 shares
@ $45.0423, valued at
$141.3k
Sold 3,847 shares
@ $45.4534, valued at
$174.9k
Sold 100 shares
@ $46.045, valued at
$4.6k
|
|
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/07/2022 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 22,500 shares
@ $39.29, valued at
$884k
Exercised 10,000 options to buy
@ $21.09, valued at
$210.9k
|
|
| 10/04/2022 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 22,500 shares
@ $31.38, valued at
$706.1k
Sold 22,500 shares
@ $34.06, valued at
$766.4k
Exercised 6,328 options to buy
@ $6.36, valued at
$40.2k
Exercised 13,672 options to buy
@ $21.09, valued at
$288.3k
|
|
| 09/15/2022 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 22,500 shares
@ $29.18, valued at
$656.6k
|
|
| 09/13/2022 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 1,007 shares
@ $21.09, valued at
$21.2k
Granted 1,152 shares
@ $8.03, valued at
$9.3k
Granted 29,074 options to buy
@ $21.1, valued at
$613.5k
Granted 29,074 options to buy
@ $21.1, valued at
$613.5k
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2020 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 1,245 shares
@ $17.068, valued at
$21.2k
Granted 77,580 options to buy
@ $28.35, valued at
$2.2M
|
|
| 03/13/2020 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Exercised 27,368 options to buy
@ $0.61, valued at
$16.7k
Exercised 22,656 options to buy
@ $0.61, valued at
$13.8k
|
|
| 12/13/2019 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 85,000 options to buy
@ $21.09, valued at
$1.8M
|
|
| 06/19/2019 |
3
| Rolph Timothy (Chief Scientific Officer) has filed a Form 3 on Akero Therapeutics, Inc. |
|
|